Reference is to the bill as introduced.
Amend the bill, as and if amended, by striking the bill in its entirety and inserting:
/ Whereas, the South Carolina General Assembly is committed to combatting the opioid epidemic occurring within this State; and
Whereas, the South Carolina General Assembly has enacted and is working to enact legislation aimed at stemming the misuse of opioids in South Carolina; and
Whereas, collecting information related to opioid use and misuse helps those working to better understand the complexities of substance abuse disorders and enables those working with patients suffering from this disease to develop strategies for treatment, education, and care; and
Whereas, the purpose of this legislation is to provide data to health care professionals treating patients who have been diagnosed with an opioid overdose and received an antidote in response to that overdose; and
Whereas, the South Carolina General Assembly intends for the information collected pursuant to this law to be used by health care professionals to assist patients in getting appropriate treatment including, but not limited to, treatment for substance abuse disorder; and
Whereas, the General Assembly intends further that the information collected pursuant to this law should not be used as the sole determining factor in a decision regarding whether to treat or refuse to treat a patient suffering from an opioid misuse. Now therefore,
Be it enacted by the General Assembly of the State of South Carolina:
SECTION 1. Chapter 130, Title 44 of the 1976 Code is amended by adding:
"Section 44-130-80.
(A) If a person is administered an
opioid antidote in a hospital emergency department or other
health care facility and the supervising physician diagnoses the
patient as having experienced an opioid overdose, the health
care facility, as defined in Section 44-7-130, shall report to
the department's Bureau of Drug Control information regarding
the opioid antidote administered for inclusion in the
prescription monitoring program. The information submitted must
include:
(1)
date the opioid antidote was administered; and
(2)
name, address, and date of birth of the person to whom the
opioid antidote was administered.
(B) The health care
facility, as defined in Section 44-7-130, shall submit the
information required pursuant to subsection (A) electronically
or by facsimile to Drug Control within thirty days after a
discharge diagnosis of an opioid overdose and administration of
an opioid antidote.
(C)(1) After a health
care facility, as defined in Section 44-7-130, submits the name,
address, and date of birth of a person to whom an opioid
antidote was administered as required by subsection (A), Drug
Control shall verify whether any prescription history of the
person appears in the prescription monitoring program and, if
prescription history exists, shall document for review by a
practitioner or an authorized delegate the date on which the
opioid antidote was administered to the person.
(2)
Drug Control also shall maintain data on the administering
of opioid antidotes as required by this section including, but
not limited to, the frequency with which opioid antidotes are
administered in hospital emergency departments as required
pursuant to subsection (A) and other health care facilities by
geographic location."
SECTION 2. Section 44-130-60 of the 1976 Code is amended by adding an appropriately lettered subsection at the end to read:
"( )(1) A first
responder who administers an opioid antidote as provided in this
section shall report to the department's Bureau of Emergency
Medical Services information regarding the opioid antidote
administered for inclusion in the prescription monitoring
program. The information submitted must include:
(a)
date the opioid antidote was administered; and
(b)
name, address, and date of birth of the person to whom the
opioid antidote was administered, if available.
(2)
A first responder shall submit the information required
pursuant to item (1) electronically or by facsimile to the
Bureau of Emergency Services within thirty days of
administration. The Bureau of Emergency Medical Services shall
transmit the information to the department's Bureau of Drug
Control.
(3)(a)
If a first responder submits the name, address, and date
of birth of a person to whom an opioid antidote was
administered, Drug Control shall verify whether any prescription
history of the person appears in the prescription monitoring
program and, if prescription history exists, shall document for
review by a practitioner or an authorized delegate the date on
which the opioid antidote was administered to the person.
(b)
Drug Control also shall maintain data on the administering
of opioid antidotes by first responders including, but not
limited to, the frequency with which first responders administer
opioid antidotes by geographic location, first responder, and
dispenser."
SECTION 3. Section 44-53-1640(A) of the 1976 Code is amended to read:
"(A) The Department of Health and Environmental Control, Bureau of Drug Control shall establish and maintain a program to monitor the prescribing and dispensing of all Schedule II, III, and IV controlled substances by professionals licensed to prescribe or dispense these substances in this State and the administering of opioid antidotes pursuant to Sections 44-130-60 and 44-130-80."
SECTION 4. Section 44-53-1645(A) of the 1976 Code is amended to read:
"(A) A practitioner, or the practitioner's authorized delegate, shall review a patient's controlled substance prescription history and history of the administering of an opioid antidote to the patient pursuant to Section 44-130-60 or 44-130-80, as maintained in the prescription monitoring program, before the practitioner issues a prescription for a Schedule II controlled substance. If an authorized delegate reviews a patient's controlled substance prescription history and history of the administering of an opioid antidote to the patient as provided in this subsection, the practitioner must consult with the authorized delegate regarding the prescription and opioid antidote administering history before issuing a prescription for a Schedule II controlled substance. The consultation must be documented in the patient's medical record."
SECTION 5. This act takes effect one year after approval by the Governor. /
Renumber sections to conform.
Amend title to conform.